Click image to enlarge
The
U-PLEX platform offers validated components that can be combined to create high quality assays quickly and easily. The U-PLEX Human Eotaxin Antibody Set is a matched pair of antibodies that can be used (with other U-PLEX components such as plates, calibrators, diluents, and MSD GOLD Read Buffer B) to build U-PLEX assays that measure Eotaxin. These assays can measure Eotaxin alone or in multiplex panels with other biomarkers. The Product Inserts in the “Documentation” tab (below) provide detailed instructions for building assays with U-PLEX Antibody Sets.
For information on multiplexing Eotaxin with other analytes, please see
U-PLEX Biomarker Group 1 (hu) Assays,
U-PLEX Metabolic Group 1 (hu) Assays, or
U-PLEX Immuno-Oncology Group 1 (hu) Assays.
-
Specifications
-
-
Kit Contents
-
Documentation
-
References
Analyte(s)
|
|
Eotaxin
|
|
Species
|
|
Human
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
2-8 °C
|
|
Gene ID(s)
|
|
6356
|
|
UniProt ID(s)
|
|
P51671
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Biotin Human Eotaxin Antibody, 1 Plate Size
|
2-8 °C
|
1 vial (1 plate size)
|
|
SULFO-TAG Human Eotaxin Antibody, 1 Plate Size
|
2-8 °C
|
1 vial (1 plate size)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Biotin Human Eotaxin Antibody, 5 Plate Size
|
2-8 °C
|
1 vial (5 plate size)
|
|
SULFO-TAG Human Eotaxin Antibody, 5 Plate Size
|
2-8 °C
|
1 vial (5 plate size)
|
|
Product Inserts
|
|
|
Datasheets
|
|
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease
|
|
|
|
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.
|
|
|
|
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters